The Treatment-Naive Microbiome in New-Onset Crohn’s DiseaseDirk Gevers, Ramnik J. Xavier, Subra Kugathasan et al.|Cell Host & Microbe|2014Cited by 3.3k
Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF TherapyJ.P. Martin, Ephraim Kenigsberg, Christie Chang et al.|Cell|2019Cited by 902
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in ChildrenJeffrey S. Hyams, Robert N. Baldassano, Wallace Crandall et al.|Gastroenterology|2006Cited by 872
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort studySubra Kugathasan, Marla C. Dubinsky, Lee A. Denson et al.|The Lancet|2017Cited by 647
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signatureYael Haberman, Lee A. Denson, Timothy L. Tickle et al.|Journal of Clinical Investigation|2014Cited by 532